Prevalence and spot urine risk factors for renal stones in children taking topiramate

Journal of Pediatric Urology

Volumn 9, Issue 6 PART A, 2013, Pages 884-889

  Corbin Bush, Nicol ^a,b,c   Twombley, Katherine ^d   Ahn, Justin ^a   Oliveira, Carlos ^a   Arnold, Susan ^b,e   Maalouf, Naim M ^a,f   Sakhaee, Khashayar ^a,f  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c Department of Urology   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e Department of Urology   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Epileptic; Kidney stones; Prevalence; Topiramate; Urolithiasis

Indexed keywords

CALCIUM; CITRIC ACID; CREATININE; TOPIRAMATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; HYPERCALCIURIA; HYPOCITRATURIA; INFANT; MALE; NEPHROLITHIASIS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TREATMENT DURATION; URINALYSIS; URINE PH;

EPILEPTIC; KIDNEY STONES; PREVALENCE; TOPIRAMATE; UROLITHIASIS;

ADOLESCENT; ALKALIES; ANTICONVULSANTS; CALCIUM; CHILD; CHILD, PRESCHOOL; CITRIC ACID; CREATININE; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; HYPERCALCIURIA; INFANT; KIDNEY CALCULI; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84887995166     PISSN: 14775131     EISSN: 18734898     Source Type: Journal    
DOI: 10.1016/j.jpurol.2012.12.005     Document Type: Article

References (31)

1. D. Lewis, P. Winner, J. Saper, S. Ness, E. Polverejan, and S. Wang Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age Pediatrics 123 2009 924 934
2. I.G. Girgis, P. Nandy, J.S. Nye, L. Ford, S. Mohanty, and S. Wang Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age Epilepsia 51 2010 1954 1962
3. G. Coppola, G. Caliendo, P. Veggiotti, A. Romeo, G. Tortorella, and P. DeMarco Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study Epilepsy Res 51 2002 147 153
4. G. Coppola, G. Capovilla, A. Montagnini, A. Romeo, M. Spano, and G. Tortorella Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial Epilepsy Res 49 2002 45 48
5. S.H. Kuo, and J. Jimenez-Shahed Topiramate in treatment of tourette syndrome Clin Neuropharmacol 33 2010 32 34
6. J. Wozniak, E. Mick, J. Waxmonsky, M. Kotarski, L. Hantsoo, and J. Biederman Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder J Child Adolesc Psychopharmacol 19 2009 539 545
7. V. Rezaei, M.R. Mohammadi, A. Ghanizadeh, A. Sahraian, M. Tabrizi, and S.A. Rezazadeh Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder Prog Neuropsychopharmacol Biol Psychiatry 34 2010 1269 1272
8. C.H. Ko, and C.K. Kong Topiramate-induced metabolic acidosis: report of two cases Dev Med Child Neurol 43 2001 701 704
9. M. Takeoka, G.L. Holmes, E. Thiele, B.F. Bourgeois, S.L. Helmers, and F.H. Duffy Topiramate and metabolic acidosis in pediatric epilepsy Epilepsia 42 2001 387 392
10. H. Philippi, R. Boor, and B. Reitter Topiramate and metabolic acidosis in infants and toddlers Epilepsia 43 2002 744 747
11. E.A. Belotti, I. Taddeo, M. Ragazzi, R. Pifferini, G.D. Simonetti, and M.G. Bianchetti Chronic impact of topiramate on acid-base balance and potassium in childhood Eur J Paediatr Neurol 14 2010 445 448
12. K. Groeper, and M.E. McCann Topiramate and metabolic acidosis: a case series and review of the literature Paediatr Anaesth 15 2005 167 170
13. S.J. Dodgson, R.P. Shank, and B.E. Maryanoff Topiramate as an inhibitor of carbonic anhydrase isoenzymes Epilepsia 41 Suppl. 1 2000 S35 S39
14. D. Vega, N.M. Maalouf, and K. Sakhaee Increased propensity for calcium phosphate kidney stones with topiramate use Expert Opin Drug Saf 6 2007 547 557
15. B.J. Welch, D. Graybeal, O.W. Moe, N.M. Maalouf, and K. Sakhaee Biochemical and stone-risk profiles with topiramate treatment Am J Kidney Dis 48 2006 555 563
16. B.W. Warner, C.A. LaGrange, T. Tucker, M. Bensalem-Owen, and V.M. Pais Jr. Induction of progressive profound hypocitraturia with increasing doses of topiramate Urology 72 2008 29 32 discussion
17. E.J. Lamb, P.E. Stevens, and L. Nashef Topiramate increases biochemical risk of nephrolithiasis Ann Clin Biochem 41 2004 166 169
18. D.M. Kaplon, K.L. Penniston, and S.Y. Nakada Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate Urology 77 2011 295 298
19. N.M. Maalouf, J.P. Langston, P.C. Van Ness, O.W. Moe, and K. Sakhaee Nephrolithiasis in topiramate users Urol Res 39 2011 303 307
20. K.K. Stamatelou, M.E. Francis, C.A. Jones, L.M. Nyberg, and G.C. Curhan Time trends in reported prevalence of kidney stones in the United States: 1976-1994 Kidney Int 63 2003 1817 1823
21. A.A. Mahmoud, T. Rizk, N.K. El-Bakri, M. Riaz, S. Dannawi, and M. Al Tannir Incidence of kidney stones with topiramate treatment in pediatric patients Epilepsia 52 2011 1890 1893
22. M. Goyal, R.I. Grossberg, M.A. O'Riordan, and I.D. Davis Urolithiasis with topiramate in nonambulatory children and young adults Pediatr Neurol 40 2009 289 294
23. R.S. Gillespie, and F.B. Stapleton Nephrolithiasis in children Pediatr Rev 25 2004 131 139
24. P. Ertan, G. Tekin, N. Oger, S. Alkan, and G.D. Horasan Metabolic and demographic characteristics of children with urolithiasis in Western Turkey Urol Res 39 2011 105 110
25. T. Akcay, D. Konukoglu, and C. Celik Hypocitraturia in patients with urolithiasis Arch Dis Child 74 1996 350 351
26. A.B. Belman, M.J. Wehle, and J.W. Segura Pediatric urolithiasis Clinical pediatric urology 4th ed 2002 Taylor and Francis Boca Raton, FL 1223 1246 Ch 38
27. H. Alpay, A. Ozen, I. Gokce, and N. Biyikli Clinical and metabolic features of urolithiasis and microlithiasis in children Pediatr Nephrol 24 2009 2203 2209
28. F.R. Spivacow, A.L. Negri, E.E. del Valle, I. Calviño, E. Fradinger, and J.R. Zanchetta Metabolic risk factors in children with kidney stone disease Pediatr Nephrol 23 2008 1129 1133
29. B.S. Battino, F.W. De, F. Coe, L. Tackett, M. Erhard, and J. Wacksman Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate? J Urol 168 2002 2568 2571
30. D.J. Parekh, J.I. Pope, M.C. Adams, and J.W. Brock 3rd The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood J Urol 164 2000 1008 1010
31. C.Y. Pak, and B. Adams-Huet Elucidation of factors determining formation of calcium phosphate stones J Urol 172 2004 2267 2270